Ausgabe 1/2023
Inhalt (27 Artikel)
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
Matthew T. Ballo, Patrick Conlon, Gitit Lavy-Shahaf, Adrian Kinzel, Josef Vymazal, Aaron M. Rulseh
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis
Juan F. Mier-García, Stefanía Ospina-Santa, Javier Orozco-Mera, Ruichong Ma, Puneet Plaha
Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain
Rea Ravin, Paola Suarez-Meade, Brad Busse, Paul S. Blank, Tito Vivas-Buitrago, Emily S. Norton, Steve Graepel, Kaisorn L. Chaichana, Ludmila Bezrukov, Hugo Guerrero-Cazares, Joshua Zimmerberg, Alfredo Quiñones-Hinojosa
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
Lorena Gurrieri, Laura Mercatali, Toni Ibrahim, Valentina Fausti, Monia Dall’Agata, Nada Riva, Nicoletta Ranallo, Giuseppe Pasini, Marcella Tazzari, Flavia Foca, Daniela Bartolini, Luca Riccioni, Chiara Cavatorta, Federico Paolo Morigi, Jenny Bulgarelli, Claudia Cocchi, Virginia Ghini, Luigino Tosatto, Giovanni Martinelli, Andrea Pession, Laura Ridolfi
Long-term follow up of patients with WHO grade 2 oligodendroglioma
Louise Carstam, Francesco Latini, Ole Solheim, Jiri Bartek Jr., Lars K. Pedersen, Maria Zetterling, Stanislav Beniaminov, Kristin Sjåvik, Mats Ryttlefors, Margret Jensdottir, Bertil Rydenhag, Anja Smits, Asgeir S. Jakola
Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors
Oluwaseun O. Akinduro, Abdul Karim Ghaith, Victor Gabriel El-Hajj, Marc Ghanem, Fatima Soltan, Antonio Bon Nieves, Kingsley Abode-Iyamah, John H. Shin, Ziya L. Gokaslan, Alfredo Quinones-Hinojosa, Mohamad Bydon
Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis
Ryuichi Noda, Mariko Kawashima, Masafumi Segawa, Sho Tsunoda, Tomohiro Inoue, Atsuya Akabane
Molecular predictors for decitabine efficacy in meningiomas – a pilot study
Dorothee C. Spille, Christian Thomas, Andrea Wagner, Oliver Martin Grauer, Julian Canisius, Eva Christine Bunk, Walter Stummer, Hans T. Eich, Werner Paulus, Volker Senner, Benjamin Brokinkel
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis
Julian P. Layer, Motaz Hamed, Anna-Laura Potthoff, Cas S. Dejonckheere, Katharina Layer, Gustavo R. Sarria, Davide Scafa, David Koch, Mümtaz Köksal, Fabian Kugel, Molina Grimmer, Jasmin A. Holz, Thomas Zeyen, Lea L. Friker, Valeri Borger, F. Carsten Schmeel, Johannes Weller, Michael Hölzel, Niklas Schäfer, Stephan Garbe, Helmut Forstbauer, Frank A. Giordano, Ulrich Herrlinger, Hartmut Vatter, Matthias Schneider, L. Christopher Schmeel
Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center
Yu-Tong Zhang, Yu Wang, Xiao-dan Zhong, Jian Chang
Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma
Xinyu Yang, Chunxia Ji, Ying Qi, Jianhan Huang, Lang Hu, Yuan Zhou, Liping Zou, Yi Xia, Feng Tan, Yu Yao, Di Chen
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial
Supriya Mallick, Subhash Gupta, Adila Amariyil, Haresh Kunhiparambath, M. A. Laviraj, Seema Sharma, Hari Krishna Raju Sagiraju, Pramod Kumar Julka, Dayanand Sharma, Goura Kishor Rath
Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers
Suchet Taori, Zhishuo Wei, Hansen Deng, Constantinos G. Hadjipanayis, L. Dade Lunsford, Ajay Niranjan
SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling
Tianyu Hu, Ruoheng Xuan, Erqiao Han, Lingshan Cai, Zhibo Xia
Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay
Murat Buyuktepe, Ibrahim Kaplan, Eyup Bayatli, Haldun Dogan, Hasan Caglar Ugur
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
Megan Mantica, Jan Drappatz, Frank Lieberman, Constantinos G. Hadjipanayis, L. Dade Lunsford, Ajay Niranjan
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
Vaseem M. Khatri, Matthew N. Mills, Daniel E. Oliver, Hsiang-Hsuan Michael Yu, Michael A. Vogelbaum, Peter A. Forsyth, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis
Paola A. Jablonska, Thiago Muniz, Mauricio Ribeiro, Zhihui Amy Liu, Xiang Y. Ye, Kaviya Devaraja, Normand Laperriere, Barbara-Ann Millar, Tatiana Conrad, Paul Kongkham, Marcus Butler, David B. Shultz
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis
Alexandra Lang, Raphael L. Jeron, Bastian Lontzek, Barbara Kiesel, Mario Mischkulnig, Anna S. Berghoff, Gerda Ricken, Adelheid Wöhrer, Karl Rössler, Daniela Lötsch-Gojo, Thomas Roetzer-Pejrimovsky, Walter Berger, Johannes A. Hainfellner, Romana Höftberger, Georg Widhalm, Friedrich Erhart
PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort
Ryohei Otani, Masachika Ikegami, Ryoji Yamada, Hirohisa Yajima, Shinji Kawamura, Sakura Shimizu, Shota Tanaka, Shunsaku Takayanagi, Hirokazu Takami, Tatsuro Yamaguchi
First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial
Matthew Holdaway, Faina Ablyazova, Shayan Huda, Randy S. D’Amico, Tamika Wong, Dana Shani, Netanel Ben-Shalom, John A. Boockvar
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience
Bryan J. Neth, Mason J. Webb, Jessica White, Joon H. Uhm, Pavel N. Pichurin, Ugur Sener
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis
Bernhard Neumann, Julia Onken, Nicole König, Henning Stetefeld, Sebastian Luger, Anna-Luisa Luger, Felix Schlachetzki, Ralf Linker, Peter Hau, Elisabeth Bumes
T2-FLAIR mismatch sign correlates with 11C-methionine uptake in lower-grade diffuse gliomas
Yusuke Ebiko, Kaoru Tamura, Shoko Hara, Motoki Inaji, Yoji Tanaka, Tadashi Nariai, Kenji Ishii, Taketoshi Maehara
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib
Aaron Lawson McLean
Correction to: Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR)
Andrew Roehrig, Daniel J. Indelicato, Arnold C. Paulino, Ralph Ermoian, William Hartsell, John Perentesis, Christine Hill-Kayser, Jae Y. Lee, Nadia N. Laack, Victor Mangona, Iain MacEwan, Bree R. Eaton, Sara Gallotto, Benjamin V. M. Bajaj, Paul D. Aridgides, Torunn I. Yock